Endothelin-1 (1-31) (Human) (TFA)

O=C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N[C@@H](CC4=CN=CN4)C(N[C@H](C(N[C@H](C(N5[C@H](C(N[C@@H](CC6=CC=C(O)C=C6)C(O)=O)=O)CCC5)=O)C(C)C)=O)C(C)C)=O)=O)CCC(O)=O)=O)CCC3)=O)[C@@H](C)O)=O)CC(N)=O)=O)C(C)C)=O)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)CC(O)=O)=O)CC(C)C)=O)CC7=CN=CN7)[C@H]8NC([C@H](CC9=CC=CC=C9)NC([C@H](CC%10=CC=C(O)C=C%10)NC([C@H](C(C)C)NC([C@]%11(NC([C@H](CCC(O)=O)NC([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CCSC)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CO)NC([C@@]([H])(NC([C@H](CO)NC([C@@H](N)CSSC8)=O)=O)CSSC%11)=O)=O)=O)=O)=O)=O)=O)=O)[H])=O)=O)=O)=O.O=C(O)C(F)(F)F

[1]Matsumoto T, et al. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides. 2008 Aug;29 (8) :1338-46.|[2]Yoshizumi M, et al. Effect of endothelin-1 (1-31) on human mesangial cell proliferation. Jpn J Pharmacol. 2000 Oct;84 (2) :146-55.